Expression of follistatin-related genes is altered in heart failure.
暂无分享,去创建一个
N. Rosenthal | M. Yacoub | E. Lara-Pezzi | P. Sarathchandra | P. Barton | E. Birks | L. Felkin | Robert S. George | Jennifer L. Hall | K. Panse
[1] K. Tsuchida,et al. Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development. , 2007, The journal of medical investigation : JMI.
[2] A. Moorman,et al. Patterns of Expression of the Follistatin and Follistatin‐Like1 Genes During Chicken Heart Development: A Potential Role in Valvulogenesis and Late Heart Muscle Cell Formation , 2007, Anatomical record.
[3] K. Patel,et al. Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation. , 2007, Cardiovascular research.
[4] T. Abraham,et al. Myostatin does not regulate cardiac hypertrophy or fibrosis , 2007, Neuromuscular Disorders.
[5] Leif Oxburgh,et al. Developmental expression of mouse Follistatin-like 1 (Fstl1): Dynamic regulation during organogenesis of the kidney and lung. , 2007, Gene expression patterns : GEP.
[6] E. Rosen,et al. FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults , 2007, Proceedings of the National Academy of Sciences.
[7] M. Yacoub,et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. , 2006, European heart journal.
[8] Magdi H Yacoub,et al. Left ventricular assist device and drug therapy for the reversal of heart failure. , 2006, The New England journal of medicine.
[9] R. Boudreau,et al. Follistatin-Like Protein-1 Is a Novel Proinflammatory Molecule1 , 2006, The Journal of Immunology.
[10] P. Aukrust,et al. Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor. , 2006, Journal of molecular and cellular cardiology.
[11] S. Cook,et al. Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling , 2006, Circulation research.
[12] P. Barton,et al. Real-time quantitative polymerase chain reaction in cardiac transplant research. , 2006, Methods in molecular biology.
[13] L. Mcleay,et al. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice , 2005, Journal of Cell Science.
[14] W. Vale,et al. Antagonists of activin signaling: mechanisms and potential biological applications , 2005, Trends in Endocrinology & Metabolism.
[15] D. Bigner,et al. Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation* , 2004, Journal of Biological Chemistry.
[16] M. Schellings,et al. Matricellular proteins in the heart: possible role during stress and remodeling. , 2004, Cardiovascular research.
[17] Eric P Hoffman,et al. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. , 2004, Developmental cell.
[18] G. Christensen,et al. Elevated Levels of Activin A in Heart Failure: Potential Role in Myocardial Remodeling , 2004, Circulation.
[19] K. Nose,et al. Structural Characterization of TSC-36/Flik , 2004, Journal of Biological Chemistry.
[20] T. Mimori,et al. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. , 2004, Arthritis and rheumatism.
[21] M. Reed,et al. Cleavage of the Matricellular Protein SPARC by Matrix Metalloproteinase 3 Produces Polypeptides That Influence Angiogenesis* , 2003, Journal of Biological Chemistry.
[22] J. Magaud,et al. FLRG, an activin-binding protein, is a new target of TGFβ transcription activation through Smad proteins , 2001, Oncogene.
[23] A. Schneyer,et al. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. , 2001, Endocrinology.
[24] K. Matthews,et al. Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.
[25] K. Boheler,et al. Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression. , 1997, Circulation.
[26] M. Kanzaki,et al. Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy , 1996, Hepatology.
[27] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.